Treat overall risk rather than LDL, two doctors urge

01/26/2012 | TheHeart.org (Montreal) (free registration)

The national panel writing education and treatment guidelines on cholesterol should abandon low-density lipoprotein targets in favor of an approach that takes overall cardiovascular risk into account, two physicians write in a letter published in the journal Circulation: Cardiovascular Quality and Outcomes. "What we know is that statins reduce risk, but they ought to be concentrated in people at higher risk," said Dr. Harlan Krumholz of the Yale University School of Medicine.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA